Fifty male children, aged between 3 and 10 years, were treated for a 12-day period with either trimethoprim (80–160 mg) plus sulphamethoxazole (400–800 mg) daily (co-trimoxazole) or 50–125 mglday flurbiprofen rectally. The patients had been treated surgically for criptorchidism. Flurbiprofen showed good effectivity in controlling post-operative inflammation in urology. It is concluded that antimicrobial agents such as co-trimoxazole, because of their potential risks of damage at the cell's level, should be used only in presence of a bacterial infection.
Get full access to this article
View all access options for this article.
References
1.
AdamsS SBurrowsC ASkeldonNYatesD B (1977) Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen. Current Medical Research and Opinion5, 11.
2.
ArndtK AJickH (1976) Rates of cutaneous reactions to drugs. Journal of the American Medical Association235, 918.
3.
BalestrierlBCostagliolaACastaldoSCapassoF (1981) Anti-inflammatory properties of the association trimethoprim-sulphamethoxazole. Drugs in Experimental Clinical Research, VII (5), 637.
4.
BenvenutiCCantoniVLongoniA (1982) Safety of flurbiprofen in a post-marketing surveillance project involving over 5,000 patients. International Meeting on Side-Effects of Anti-Inflammatory Analgesic Drugs – Verona, Sept 13–15, (abstract).
5.
GoldingJ ROfeiE S AsleduDayA T (1980) A comparison of flurbiprofen and indomethacin in the treatment of rheumatoid disease. British Journal of Clinical Practice9, 43.
6.
MantelN (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports50, 3.
7.
ScraggJ NRubidgeC J (1971) Trimethoprim and sulphamethoxazole in typhoid fever in children. British Medical Journal3, 738.
